New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
07:38 EDTZLTQZELTIQ could get boost from new product, says Stifel
After ZELTIQ introduced CoolSmooth, Stifel reports that the company is working with the FDA to enable the product to be used on thighs. After conducting checks, the firm sees significant demand for a thigh indication and believes that the new product increases the chances that the company's results will beat expectations. Stifel keeps a $28 price target and Buy rating on the shares.
News For ZLTQ From The Last 14 Days
Check below for free stories on ZLTQ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 19, 2014
08:13 EDTZLTQZELTIQ price target raised to $28 from $24 at Canaccord
Canaccord raised its price target on ZELTIQ to $28 from $24 following its analyst day. The firm cited confidence in the new sales organization structure, its focus on new products, and the potential for accelerating worldwide sales. Canaccord maintains its Buy rating on ZELTIQ shares.
07:53 EDTZLTQZELTIQ price target raised to $32 from $28 at Stifel
Stifel increased its price target on ZELTIQ as the firm is more upbeat about the sustainability of the company's growth rate following its checks and the company's Analyst Day. Stifel believes that the company's marketing initiatives are gaining momentum. It keeps a $32 price target and Buy rating on the shares.
September 18, 2014
10:15 EDTZLTQZELTIQ reaffirms 2014 revenue outlook $160M-$165M
Subscribe for More Information
September 16, 2014
06:20 EDTZLTQZELTIQ to host investor day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use